$147.46
1.91% yesterday
NYSE, Jun 09, 10:10 pm CET
ISIN
US1598641074
Symbol
CRL

Charles River Laboratories International, Inc. Stock price

$147.46
+8.67 6.25% 1M
-54.29 26.91% 6M
-37.14 20.12% YTD
-67.05 31.26% 1Y
-32.87 18.23% 5Y
+74.55 102.25% 10Y
+100.84 216.30% 20Y
NYSE, Closing price Mon, Jun 09 2025
+2.76 1.91%
ISIN
US1598641074
Symbol
CRL
Sector
Industry

Key metrics

Market capitalization $7.24b
Enterprise Value $9.53b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 16.92
EV/Sales (TTM) EV/Sales 2.37
P/S ratio (TTM) P/S ratio 1.80
P/B ratio (TTM) P/B ratio 2.27
Revenue growth (TTM) Revenue growth -2.16%
Revenue (TTM) Revenue $4.02b
EBIT (operating result TTM) EBIT $506.37m
Free Cash Flow (TTM) Free Cash Flow $563.24m
Cash position $229.42m
EPS (TTM) EPS $-0.62
P/E forward 33.01
P/S forward 1.86
EV/Sales forward 2.45
Short interest 6.47%
Show more

Is Charles River Laboratories International, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,825 stocks worldwide.

Charles River Laboratories International, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

19 Analysts have issued a Charles River Laboratories International, Inc. forecast:

5x Buy
26%
13x Hold
68%
1x Sell
5%

Analyst Opinions

19 Analysts have issued a Charles River Laboratories International, Inc. forecast:

Buy
26%
Hold
68%
Sell
5%

Financial data from Charles River Laboratories International, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4,023 4,023
2% 2%
100%
- Direct Costs 2,627 2,627
1% 1%
65%
1,395 1,395
7% 7%
35%
- Selling and Administrative Expenses 718 718
3% 3%
18%
- Research and Development Expense - -
-
-
678 678
11% 11%
17%
- Depreciation and Amortization 171 171
27% 27%
4%
EBIT (Operating Income) EBIT 506 506
19% 19%
13%
Net Profit -32 -32
107% 107%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Charles River Laboratories International, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Charles River Laboratories International, Inc. Stock News

Neutral
Business Wire
8 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at William Blair and Jefferies Conferences.
Neutral
Business Wire
13 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River and CHDI announce an extension of their partnership, having worked together since 2005 to expedite therapies for Huntington's disease.
Neutral
Business Wire
28 days ago
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories to Present at Bank of America Health Care Conference.
More Charles River Laboratories International, Inc. News

Company Profile

Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Head office United States
CEO James Foster
Employees 19,400
Founded 1947
Website www.criver.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today